Cholangiocarcinoma Market Size is estimated to grow at a CAGR of 4.2% during the forecast period
The cholangiocarcinomas market was estimated to be worth USD 860 million in 2022, and during the forecast period, a CAGR of 4.2% is anticipated. Surgery is the sole available treatment for cholangiocarcinoma. Chemotherapy helps for a while, but surgery is the only way to cure someone permanently. Bile cancer, or cholangiocarcinoma, is a disease that affects the liver both internally and externally. This type of cancer has very little risk of coming back. In cholangiocarcinoma, the malignant cancer cells proliferate in the bile duct. The liver, small intestine, and gall bladder are connected by a network of tubes called the bile duct. Workers are suffering as a result of increased exposure to hazardous chemicals used in printing and other applications. Treatment for bile duct cancer is therefore anticipated to become more and more common in the medical community. The market will expand quickly as a result of increased awareness among public and private entities about the effect...